Deep Dives

Deep Dives

Investment decisions require more than intuition — they demand rigorous research.

Our Investment team dedicates significant time and resources to deeply studying every opportunity we consider.

We're committed to sharing this work because we believe the insights and learnings we gain can benefit others in the healthcare investment space.

This section features our most valuable research and analysis, distilled into accessible deep dives on the issues and trends shaping our industry.

TechBio

In 2020, the boom in biotech and AI gave rise to TechBio, focused on speeding drug development. After intense early funding, progress slowed as results and valuations diverged.
Angelini Ventures aims to clarify AI’s real impact and define success for TechBio.